VELOSEF Drug Patent Profile
✉ Email this page to a colleague
When do Velosef patents expire, and when can generic versions of Velosef launch?
Velosef is a drug marketed by Apothecon, Bristol Myers Squibb, and Ersana. and is included in five NDAs.
The generic ingredient in VELOSEF is cephradine. There are ten drug master file entries for this compound. Additional details are available on the cephradine profile page.
Summary for VELOSEF
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 4,820 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VELOSEF at DailyMed |
US Patents and Regulatory Information for VELOSEF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | VELOSEF | cephradine | CAPSULE;ORAL | 061764-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | VELOSEF | cephradine | INJECTABLE;INJECTION | 061976-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | VELOSEF | cephradine | INJECTABLE;INJECTION | 061976-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ersana | VELOSEF '500' | cephradine | CAPSULE;ORAL | 050548-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VELOSEF | cephradine | TABLET;ORAL | 050530-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | VELOSEF | cephradine | CAPSULE;ORAL | 061764-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |